TickerFacts.

Meihua International Medical Technologies Co., Ltd. (MHUAF): R&D Expense

Annual figures by period end, from SEC filings.

$2.38M
Year ended 2025-12-31
-7.0%
3-year compound annual growth
-0.9%
5-year compound annual growth
$3.46M2019-12-31: $3.21M2020-12-31: $2.49M2021-12-31: $2.73M2022-12-31: $2.96M2023-12-31: $2.75M2024-12-31: $3.46M2025-12-31: $2.38M$2.38M
2019-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$2.38M-31.0%2026-04-29, From 2025-01-01
2024-12-31$3.46M+25.5%2026-04-29, From 2024-01-01
2023-12-31$2.75M-7.1%2026-04-29, From 2023-01-01
2022-12-31$2.96M+8.7%2025-04-25, From 2022-01-01
2021-12-31$2.73M+9.3%2024-04-24, From 2021-01-01
2020-12-31$2.49M-22.5%2023-08-29, From 2020-01-01
2019-12-31$3.21Mn/a2022-07-29, From 2019-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Meihua International Medical Technologies Co., Ltd. (MHUAF)2025-12-31$2.38M-31.0%
LENSAR, Inc. (LNSR)2025-12-31$5.62M+5.5%
CVRx, Inc. (CVRX)2025-12-31$11.13M0.0%
AVITA Medical, Inc. (RCEL)2025-12-31$20.84M+2.4%
Apyx Medical Corp (APYX)2025-12-31$3.37M-33.6%
Carlsmed, Inc. (CARL)2025-12-31$17.02M+19.0%
Sight Sciences, Inc. (SGHT)2025-12-31$14.61M-18.8%
PRO DEX Inc (PDEX)2026-06-30$3.35M-8.0%
TELA Bio, Inc. (TELA)2025-12-31$9.22M+4.6%

Compare MHUAF, LNSR, CVRX, RCEL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗